ASH 2023: MRD Highlights in BioPharma Drug Development

Read More

Immune and circulating tumor DNA profiling following radiation treatment for oligometastatic NSCLC; translational correlatives from a mature randomized phase II trial

Tang et al.
International Journal of Radiation Oncology &Biology & Physics
October 2019
Authors and Affiliates
Tang C1, Lee WC2, Reuben A3, Chang L4, Tran H3, Little L5, Gumbs C5, Wargo J6, Futreal A5, Liao Z7, Xia X4, Yi X4, Swisher SG8, Heymach JV9, Gomez D10, Zhang J11; 1 Departments of Radiation Oncology; Investigational Cancer Therapeutics, MD Anderson Cancer Center, Houston TX USA. 2 Genomic Medicine; Thoracic/Head and Neck Medical Oncology. 3 Thoracic/Head and Neck Medical Oncology. 4 Geneplus institute-Beijing, Beijing China. 5 Genomic Medicine. 6 Genomic Medicine; Surgical Oncology. 7 Departments of Radiation Oncology. 8 Thoracic Surgery. 9 Thoracic/Head and Neck Medical Oncology. Electronic address: jheymach@mdanderson.org. 10 Departments of Radiation Oncology. Electronic address: dgomez@mdanderson.org. 11 Genomic Medicine; Thoracic/Head and Neck Medical Oncology. Electronic address: jzhang20@mdanderson.org